Effect of High-Dose or Split-Dose Artesunate on Parasite Clearance in Artemisinin-Resistant Falciparum Malaria
Author(s) -
Debashish Das,
Rupam Tripura,
Aung Pyae Phyo,
Khin Maung Lwin,
Joel Tärning,
Sue J. Lee,
Warunee Hanpithakpong,
Kasia Stepniewska,
Didier Ménard,
Pascal Ringwald,
Kamolrat Silamut,
Mallika Imwong,
Kesinee Chotivanich,
Poravuth Yi,
Nicholas Day,
Niklas Lindegårdh,
Duong Socheat,
Chea Nguon,
Nicholas J. White,
François Nosten,
Arjen M. Dondorp
Publication year - 2012
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cis958
Subject(s) - artesunate , artemisinin , medicine , parasitemia , malaria , dihydroartemisinin , plasmodium falciparum , mefloquine , pharmacology , interquartile range , immunology
The emergence of Plasmodium falciparum resistance to artemisinins on the Cambodian and Myanmar-Thai borders poses severe threats to malaria control. We investigated whether increasing or splitting the dose of the short-half-life drug artesunate improves parasite clearance in falciparum malaria in the 2 regions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom